期刊文献+

冠心病合并焦虑和/或抑郁情绪患者血清髓过氧化物酶和脂氧素A4水平的变化 被引量:20

Change of serum myeloperoxidase and lipoxin A4 level in coronary heart disease patients with anxiety and/or depression
下载PDF
导出
摘要 目的:探讨冠心病合并焦虑和/或抑郁情绪患者血清髓过氧化物酶(myeloperoxidase,MPO)和脂氧素A4(lipoxin A4,LXA4)水平的变化及临床意义。方法:选择2010年12月至2011年2月在中南大学湘雅二医院心内科住院确诊为冠心病的患者143例为研究对象,并以44例非冠心病者作为对照,使用医院焦虑抑郁情绪评定表(Thehospital anxiety and depression scale,HADS)评价患者的心理状态,将冠心病患者分为焦虑抑郁组(n=57)及非焦虑抑郁组(n=86)。测定所有研究对象的血清高敏C反应蛋白(high sensitive C-reactive protein,HsCRP),MPO,LXA4水平,计算LXA4与MPO比值(M/L)。结果:冠心病两组的血清HsCRP,LXA4,MPO水平和M/L均较对照组明显升高(均P<0.01),其中以冠心病焦虑抑郁组升高更为明显,与非焦虑抑郁组相比MPO和M/L差异有统计学意义(P<0.05)。相关分析发现MPO与HADS总表(HADS total,HADS-t)、焦虑亚量表(HADS-anxiety,HADS-a)或抑郁亚量表(HADS-depression,HADS-d)评分呈正相关,LXA4与HADS-t或HADS-d评分呈负相关。多因素logistic回归分析显示,较高的HADS-t评分、稳定型心绞痛、不稳定型心绞痛和急性心肌梗死是M/L升高的独立影响因子(P<0.05或P<0.01)。结论:焦虑和/或抑郁情绪可能加重冠心病患者体内的炎症反应,炎症与抗炎之间的失衡可能是其重要机制之一。 Objective: To investigate the change of serum myeloperoxidase (MPO) and lipoxin A4 (LXA4) in coronary heart disease (CHD) patients with anxiety and depression and its clinical significance. Methods: From December 2010 to February 2011, 143 CHD patients and 44 non-CHD patients (the control group) hospitalized in the Department of Cardiology at the Second Xiangya Hospital were enrolled. The hospital anxiety and depression scale (HADS) was used to evaluate the psychological state of all patients and the CHD patients were assigned to an anxiety and depression group (n=57) or a non-depression and anxiety group (n=86). The serum levels of high sensitive C-reactive protein (Hs-CRP), MPO, and LXA4 were examined, and the ratio of MPO and LXA4 (M/L) was calculated. Results: q-he levels of Hs-CRP, MPO, and LXA4 as well as M/L ratios in both CHD groups were significantly higher than those in the control group (all P〈0.01). Compared with the non-anxiety and depression group, the levels of MPO and LXA4, and M/L ratios in the anxiety and depression group increased (all P〈0.05). Correlation analysis showed that MPO was positively correlated with the score ofHADS-total (HADS-t), HADS-anxiety (HADS-a), or HADS-depression (HADS-d), while LXA4 was negatively correlated with HADS-t or HADS-d. Multiple ordinal logistic regression analysis revealed that higher HADS-t score, stable angina, unstable angina, and acute myocardial infarction were the independent impact factors for the elevation of M/L ratio. Conclusion: Anxiety and depression may aggravate the inflammatory response in CHD patients. The imbalance between inflammation and anti-inflammation maybe part of the mechanism.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期370-375,共6页 Journal of Central South University :Medical Science
关键词 冠心病 焦虑 抑郁 炎症 髓过氧化物酶 脂氧素 coronary heart disease anxiety depression inflammation myeloperoxidase lipoxin
  • 相关文献

参考文献16

  • 1Libby P, Okamoto Y, Rocha VZ, et al. Inflammation in atherosclerosis: Transition from theory to practice[J]. Circ J, 2010, 74(2): 213-220.
  • 2Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum level predict risk in patients with acute coronary syndromes[J]. Circulation, 2003, 108(12): 1440-1445.
  • 3Aksoy SN, Sayglh El, Bulbul F, et al. Myeloperoxidase enzyme levels and oxidative stress in bipolar disorders[J]. AfrJ Biotechnol, 2010, 9(22): 3318-3323.
  • 4Das UN. Lipoxins, resolvins, protectins, maresins, and nitrolipids: Connecting lipidsj inflammation, and cardiovascular disease risk[J]. Curr Cardio Risk Rep, 2010, 4:24-31.
  • 5李倩,毛应启梁,王彦青.脂氧素在神经系统疾病中的保护作用[J].国际病理科学与临床杂志,2010,30(5):411-414. 被引量:4
  • 6Singh U, Devaraj S, Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: Implications for acute coronary syndromes[J]. Clin Chem, 2009, 55(2): 361-364.
  • 7Roman RM, Wendland AE, Polanczyk CA, et al. Myeloperoxidase and coronary arterial disease: From research to clinical practice[J]. Arq Bras Cardiol, 2007, 91(1): ell-el8.
  • 8Kubala L, Lu G, Baldus S, et al. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease[J]. Clin China Acta, 2008, 394(1/2): 59-62.
  • 9Lesp:rance F, Frasure-Smith N, Th:roux P, et al. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes[J]. AmJ Psychiatry, 2004, 161(2): 271-277.
  • 10Pizzi C, Manzoli L, Mancini S. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function[J]. Europ Heart J, 2008, 29(9): 1110-1117.

二级参考文献35

  • 1Serhan CN.Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis:an update and role in anti-inflammation and pro-resolution[J].Prostaglandins Other Lipid Mediat,2002,68-69:433-455.
  • 2Maderna P,Godson C.Lipoxins:resolutionary road[J].BJP,2009,158(4):947-959.
  • 3Tuttolomondo A,DiRaimondo D,Pinto A,et al.Inflammatory cytokines in acute ischemic stroke[J].Curr Pharm Design,2008,14(33):3574-3589.
  • 4Baker N,O'Meara SJ,Scannell M,et al.Lipoxin A4:anti-inflammatory and anti-angiogenic impact on endothelial cells[J].J Immunol,2009,182(6):3819-3826.
  • 5Serhan CN,Hamberg M,Samuelsson B.Lipoxins-novel series of biologically active compounds formed from arachidonic acid in human leukocytes[J].Proc Natl Acad Sci U S A,1984,81(17):5335-5339.
  • 6Serhan CN.Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution[J].Prostag Leukotr Ess,2005,73(3-4):141-162.
  • 7Hersberger M.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis:leukotrienes,lipoxins and resolvins[J].Clin Chem Lab Med,2010,48(8):1063-1073.
  • 8Ryan A,Godson C.Lipoxins:regulators of resolution.[J].Curr Opin Pharmacol,2010,10(2):166-172.
  • 9Fierro IM,Serhan CN.Mechanisms in anti-inflammation and resolution:the role of lipoxins and aspirin-triggered lipoxins[J].Braz J Med Biol Res,2001,34(5):555-566.
  • 10McMahon B,Stenson C,McPhlillips F,et al.Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells differential activation of MAP kinases through distinct receptors[J].JBC,2000,275(36):27566-27575.

共引文献69

同被引文献255

引证文献20

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部